When CCR made a £2 million fairness funding in Pharmatelligence again in 2020, we have been proud to assist a world-class analysis crew that transforms routine healthcare information into clear, dependable and replicable proof – serving to pharmaceutical firms, academia, regulatory authorities and well being companions drive more practical drug discovery, proof of worth for cash and higher well being outcomes for hundreds of thousands of sufferers.
The final two years have seen a quick evolution of this extraordinary enterprise. An extra £2m funding from CCR this 12 months has enabled this pioneering crew to double in dimension, rebrand to change into Human Knowledge Sciences, and launch the revolutionary Livingstone platform.
We spoke with CEO Rhiannon Thomason in regards to the journey up to now and the street forward for this multi-disciplinary crew who’re remodeling well being and wellbeing the world over from a singular vantage level utilising modern information evaluation and cloud computing. …
